These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 15004194)

  • 1. Critical protection from renal ischemia reperfusion injury by CD55 and CD59.
    Yamada K; Miwa T; Liu J; Nangaku M; Song WC
    J Immunol; 2004 Mar; 172(6):3869-75. PubMed ID: 15004194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking properdin, the alternative pathway, and anaphylatoxin receptors ameliorates renal ischemia-reperfusion injury in decay-accelerating factor and CD59 double-knockout mice.
    Miwa T; Sato S; Gullipalli D; Nangaku M; Song WC
    J Immunol; 2013 Apr; 190(7):3552-9. PubMed ID: 23427256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Human CD55 and CD59 or Treatment with Human CD55 Protects against Renal Ischemia-Reperfusion Injury in Mice.
    Bongoni AK; Lu B; Salvaris EJ; Roberts V; Fang D; McRae JL; Fisicaro N; Dwyer KM; Cowan PJ
    J Immunol; 2017 Jun; 198(12):4837-4845. PubMed ID: 28500075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protective role of CD59 and pathogenic role of complement in hepatic ischemia and reperfusion injury.
    Zhang J; Hu W; Xing W; You T; Xu J; Qin X; Peng Z
    Am J Pathol; 2011 Dec; 179(6):2876-84. PubMed ID: 22019898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack.
    Miwa T; Zhou L; Hilliard B; Molina H; Song WC
    Blood; 2002 May; 99(10):3707-16. PubMed ID: 11986227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predominant role for C5b-9 in renal ischemia/reperfusion injury.
    Zhou W; Farrar CA; Abe K; Pratt JR; Marsh JE; Wang Y; Stahl GL; Sacks SH
    J Clin Invest; 2000 May; 105(10):1363-71. PubMed ID: 10811844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decay-accelerating factor but not CD59 limits experimental immune-complex glomerulonephritis.
    Bao L; Haas M; Minto AW; Quigg RJ
    Lab Invest; 2007 Apr; 87(4):357-64. PubMed ID: 17259999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting the complement system does not reduce injury in renal ischemia reperfusion.
    Park P; Haas M; Cunningham PN; Alexander JJ; Bao L; Guthridge JM; Kraus DM; Holers VM; Quigg RJ
    J Am Soc Nephrol; 2001 Jul; 12(7):1383-1390. PubMed ID: 11423567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respective roles of decay-accelerating factor and CD59 in circumventing glomerular injury in acute nephrotoxic serum nephritis.
    Lin F; Salant DJ; Meyerson H; Emancipator S; Morgan BP; Medof ME
    J Immunol; 2004 Feb; 172(4):2636-42. PubMed ID: 14764738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD59a deficiency exacerbates ischemia-reperfusion injury in mice.
    Turnberg D; Botto M; Lewis M; Zhou W; Sacks SH; Morgan BP; Walport MJ; Cook HT
    Am J Pathol; 2004 Sep; 165(3):825-32. PubMed ID: 15331407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-level co-expression of complement regulators on vascular endothelium in transgenic mice: CD55 and CD59 provide greater protection from human complement-mediated injury than CD59 alone.
    Cowan PJ; Shinkel TA; Aminian A; Romanella M; Wigley PL; Lonie AJ; Nottle MB; Pearse MJ; d'Apice AJ
    Xenotransplantation; 1998 Aug; 5(3):184-90. PubMed ID: 9741456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissecting the complement pathway in hepatic injury and regeneration with a novel protective strategy.
    Marshall KM; He S; Zhong Z; Atkinson C; Tomlinson S
    J Exp Med; 2014 Aug; 211(9):1793-805. PubMed ID: 25113972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-mediated gene transfer of double human complement regulating proteins (DAF, CD59) in xenogeneic rat kidney perfusion.
    Nagahama M; Shiraishi M; Taira K; Ohshiro T; Muto Y
    Transplant Proc; 2000 Aug; 32(5):909-10. PubMed ID: 10936269
    [No Abstract]   [Full Text] [Related]  

  • 14. CD59 but not DAF deficiency accelerates atherosclerosis in female ApoE knockout mice.
    An G; Miwa T; Song WL; Lawson JA; Rader DJ; Zhang Y; Song WC
    Mol Immunol; 2009 May; 46(8-9):1702-9. PubMed ID: 19297024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CD59, a regulator of the membrane attack complex of complement, on human skeletal muscle fibers.
    Navenot JM; Villanova M; Lucas-Héron B; Malandrini A; Blanchard D; Louboutin JP
    Muscle Nerve; 1997 Jan; 20(1):92-6. PubMed ID: 8995588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel bifunctional chimeric complement inhibitor that regulates C3 convertase and formation of the membrane attack complex.
    Fodor WL; Rollins SA; Guilmette ER; Setter E; Squinto SP
    J Immunol; 1995 Nov; 155(9):4135-8. PubMed ID: 7594566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of different combinations of human MCP, DAF, and CD59 on complement-dependent cytolysis in NIH 3T3 cells.
    Yang X; Deng J; Jiang Z; Liao DJ; Jiang H
    Exp Clin Transplant; 2012 Feb; 10(1):49-54. PubMed ID: 22309420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of xenogeneic cardiac endothelium from human complement by expression of CD59 or DAF in transgenic mice.
    Byrne GW; McCurry KR; Kagan D; Quinn C; Martin MJ; Platt JL; Logan JS
    Transplantation; 1995 Nov; 60(10):1149-56. PubMed ID: 7482724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shear stress-mediated changes in the expression of complement regulatory protein CD59 on human endothelial progenitor cells by ECM-integrinα
    Cui X; Zhang X; Bu H; Liu N; Li H; Guan X; Yan H; Wang Y; Zhang H; Ding Y; Cheng M
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):416-421. PubMed ID: 28943429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9 generated human CD46, CD55 and CD59 knockout cell lines as a tool for complement research.
    Thielen AJF; van Baarsen IM; Jongsma ML; Zeerleder S; Spaapen RM; Wouters D
    J Immunol Methods; 2018 May; 456():15-22. PubMed ID: 29447841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.